Anyone assigned female at birth might prefer Hers to Hims for certain treatments
Chhaya Makhija, MD, DipABLM Board-Certified Endocrinologist | Lifestyle Medicine Physician | Founder, Unified Endocrine & Diabetes Care Lafayette Fresno California Telemedicine (including Silicon Valley, Palo Alto, Menlo Park, San Francisco, Walnut Creek, Oakland, Sacramento) Watch or Listen to the Full Episode For a deeper dive into the science and real-world clinical nuance:
Dont let another day go by feeling discouraged about your weight loss journey
When one system slows, all others feel the burden
For researchers choosing between the two most potent compounds in this class, retatrutide currently shows a 1.52 percentage-point weight-loss advantage over tirzepatide at comparable durations, but tirzepatide carries substantially more Phase 3 evidence and a confirmed MHRA authorisation [1][2]
The ability to regain your sense of smell depends on the underlying cause